Literature DB >> 18316653

Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in African subjects.

Lise Bankir1, Murielle Bochud, Marc Maillard, Pascal Bovet, Anne Gabriel, Michel Burnier.   

Abstract

Blood pressure (BP) follows a circadian rhythm, with 10% to 15% lower values during nighttime than during daytime. The absence of a nocturnal BP decrease (dipping) is associated with target organ damage, but the determinants of dipping are poorly understood. We assessed whether the nighttime BP and the dipping are associated with the circadian pattern of sodium excretion. Ambulatory BP and daytime and nighttime urinary electrolyte excretion were measured simultaneously in 325 individuals of African descent from 73 families. When divided into sex-specific tertiles of day:night ratios of urinary sodium excretion rate, subjects in tertile 1 (with the lowest ratio) were 6.5 years older and had a 9.8-mm Hg higher nighttime systolic BP (SBP) and a 23% lower SBP dipping (expressed in percentage of day value) compared with subjects in tertile 3 (P for trend <0.01). After adjustment for age, the SBP difference across tertiles decreased to 5.4 mm Hg (P=0.002), and the SBP dipping difference decreased to 17% (P=0.05). A similar trend across tertiles was found with diastolic BP. In multivariate analyses, daytime urinary sodium and potassium concentrations were independently associated with nighttime SBP and SBP dipping (P<0.05 for each). These data, based on a large number of subjects, suggest that the capacity to excrete sodium during daytime is a significant determinant of nocturnal BP and dipping. This observation may help us to understand the pathophysiology and clinical consequences of nighttime BP and to develop therapeutic strategies to normalize the dipping profile in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316653     DOI: 10.1161/HYPERTENSIONAHA.107.105510

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  57 in total

1.  Associations of Urinary Uromodulin with Clinical Characteristics and Markers of Tubular Function in the General Population.

Authors:  Menno Pruijm; Belen Ponte; Daniel Ackermann; Fred Paccaud; Idris Guessous; Georg Ehret; Antoinette Pechère-Bertschi; Bruno Vogt; Markus G Mohaupt; Pierre-Yves Martin; Sonia C Youhanna; Nadine Nägele; Peter Vollenweider; Gérard Waeber; Michel Burnier; Olivier Devuyst; Murielle Bochud
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-18       Impact factor: 8.237

Review 2.  Hypertension in African Americans.

Authors:  Nomsa Musemwa; Crystal A Gadegbeku
Journal:  Curr Cardiol Rep       Date:  2017-10-28       Impact factor: 2.931

Review 3.  Nycthemeral relationship between renal function and sodium homeostasis.

Authors:  Peter W de Leeuw
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

Review 4.  Vasopressin: a novel target for the prevention and retardation of kidney disease?

Authors:  Lise Bankir; Nadine Bouby; Eberhard Ritz
Journal:  Nat Rev Nephrol       Date:  2013-02-26       Impact factor: 28.314

5.  Altered circadian hemodynamic and renal function in cirrhosis.

Authors:  Suthat Liangpunsakul; Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

Review 6.  Pressure natriuresis and the renal control of arterial blood pressure.

Authors:  Jessica R Ivy; Matthew A Bailey
Journal:  J Physiol       Date:  2014-08-08       Impact factor: 5.182

Review 7.  Circadian regulation of kidney function: finding a role for Bmal1.

Authors:  Dingguo Zhang; David M Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2017-12-20

Review 8.  Role of circadian rhythms in potassium homeostasis.

Authors:  Michelle L Gumz; Lawrence Rabinowitz
Journal:  Semin Nephrol       Date:  2013-05       Impact factor: 5.299

9.  Short-term reproducibility of ambulatory blood pressure monitoring in autosomal dominant polycystic kidney disease.

Authors:  Frederic F Rahbari-Oskoui; Dana C Miskulin; Marie C Hogan; Odicie Fielder; Vicente E Torres; James E Bost; Arlene Beth Chapman
Journal:  Blood Press Monit       Date:  2011-04       Impact factor: 1.444

10.  AHA/ACC-defined stage 1 hypertensive adults do not display cutaneous microvascular endothelial dysfunction.

Authors:  Gabrielle A Dillon; Jody L Greaney; Sean Shank; Urs A Leuenberger; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-07-31       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.